Chromosomal 3 and 8 status within hepatic metastasis of uveal melanoma

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 8, 2009, Pages 1223-1227

  Singh, Arun D ^a,b   Tubbs, Raymond ^a   Biscotti, Charles ^a   Schoenfield, Lynn ^a   Trizzoi, Pierre ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; PARAFFIN; DNA; DNA BINDING PROTEIN; MYCBP PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; AGED; ANEUSOMY; ARTICLE; CHROMOSOME 3; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE LOCUS; GENE PROBE; HUMAN; HUMAN TISSUE; INTERPHASE; LIVER METASTASIS; MALE; MONOSOMY; MONOSOMY 3; NEEDLE BIOPSY; ONCOGENE C MYC; PRIMARY TUMOR; UVEA MELANOMA; ANEUPLOIDY; CHROMOSOME 8; ENUCLEATION; GENETICS; LIVER TUMOR; MELANOMA; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; UVEA TUMOR;

ADULT; AGED; ANEUPLOIDY; BIOPSY, NEEDLE; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; DNA, NEOPLASM; DNA-BINDING PROTEINS; EYE ENUCLEATION; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 69149103047     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res. 2001;11(3):1-9.
2. Prescher G, Bornfeld N, Becher R. Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst. 1990;82(22):1765-1769.
3. Sisley K, Cottam DW, Rennie IG, et al. Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma. Genes Chromosomes Cancer. 1992;5(3):197-200. (Pubitemid 27193716)
4. Wiltshire RN, Elner VM, Dennis T, Vine AK, Trent JM. Cytogenetic analysis of posterior uveal melanoma. Cancer Genet Cytogenet. 1993;66(1):47-53. (Pubitemid 23110247)
5. Horsman DE, WhiteVA. Cytogenetic analysis of uveal melanoma: consistent occurrence of monosomy 3 and trisomy 8q. Cancer. 1993;71(3):811-819.
6. Singh AD, Boghosian-Sell L,Wary KK, et al. Cytogenetic findings in primary uveal melanoma. Cancer Genet Cytogenet. 1994;72(2):109-115. (Pubitemid 24161943)
7. Prescher G, Bornfeld N, Friedrichs W, Seeber S, Becher R. Cytogenetics of twelve cases of uveal melanoma and patterns of nonrandom anomalies and isochromosome formation. Cancer Genet Cytogenet. 1995;80(1):40-46.
8. Sisley K, Rennie IG, Parsons MA, et al. Abnormalities of chromosome 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer. 1997;19(1):22-28. (Pubitemid 27193716)
9. Sisley K, Parsons MA, Garnham J, et al. Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma. Br J Cancer. 2000;82(2):330-338. (Pubitemid 30045378)
10. Hoglund M, Gisselsson D, Hansen GB, et al. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer. 2004;108(1):57-65. (Pubitemid 37444444)
11. Loercher AE, Harbour JW. Molecular genetics of uveal melanoma. Curr Eye Res. 2003;27(2):69-74.
12. Singh AD, Damato B, Howard P, Harbour JW. Uveal melanoma: genetic aspects. Ophthalmol Clin North Am. 2005;18(1):85-97, viii.
13. Patel KA, Edmondson ND, Talbot F, Parsons MA, Rennie IG, Sisley K. Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation. Br J Ophthalmol. 2001;85(12):1440-1444. (Pubitemid 34032910)
14. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007;114(10):1925-1931.
15. Royds JA, Sharrard RM, Parsons MA, et al. C-myc oncogene expression in ocular melanomas. Graefes Arch Clin Exp Ophthalmol. 1992;230(4):366-371.
16. Parrella P, Caballero OL, Sidransky D, Merbs SL. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Invest Ophthalmol Vis Sci. 2001;42(8):1679-1684. (Pubitemid 32652337)
17. Chana JS, Wilson GD, Cree IA, et al. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma. Br J Ophthalmol. 1999;83(1):110-114.
18. Singh AD, Kivela T. The collaborative ocular melanoma study. Ophthalmol Clin North Am. 2005;18(1):129-142.
19. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12(8):895-904. (Pubitemid 44175140)
20. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet. 2007;8(5):341-352.
21. Singh AD, Borden EC. Metastatic uveal melanoma. Ophthalmol Clin North Am. 2005;18(1):143-150.
22. Rey JA, Bello MJ, de Campos JM, Ramos MC, Benitez J. Cytogenetic findings in a human malignant melanoma metastatic to the brain. Cancer Genet Cytogenet. 1985;16(2):179-183. (Pubitemid 15103542)
23. Parada LA, Maranon A, Hallen M, et al. Cytogenetic analyses of secondary liver tumors reveal significant differences in genomic imbalances between primary and metastatic colon carcinomas. Clin Exp Metastasis. 1999;17(6):471-479. (Pubitemid 30182740)
24. Aalto Y, Eriksson L, Seregard S, Larsson O, Knuutila S. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42(2): 313-317. (Pubitemid 32121456)
25. Horsman DE, Sroka H, Rootman J, White VA. Monosomy 3 and isochromosome 8q in a uveal melanoma. Cancer Genet Cytogenet. 1990;45(2):249-253.
26. Parrella P, Sidransky D, Merbs SL. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res. 1999; 59(13):3032-3037. (Pubitemid 29315995)
27. Hausler T, Stang A, Anastassiou G, et al. Loss of heterozygosity of 1p in uveal melanomas with monosomy 3. Int J Cancer. 2005;116(6):909-913. (Pubitemid 41209197)
28. Kilic E, Naus NC, van Gils W, et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci. 2005;46(7):2253-2257. (Pubitemid 43119466)
29. Ulmer A, Schmidt-Kittler O, Fischer J, et al. Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Clin Cancer Res. 2004;10(2):531-537. (Pubitemid 38173991)